Sana Biotechnology will lay off 29% of workforce
GeekWire
OCTOBER 10, 2023
Sana Biotechnology will reduce its workforce by 29%, the Seattle-based cell and gene therapy company revealed in a SEC filing Tuesday. The company said it is increasing focus on its ex vivo cell therapy product candidates, resulting in a “strategic re-positioning” and delaying other projects.
Let's personalize your content